Changes in Human Immunodeficiency Virus Type 1 Populations after Treatment Interruption in Patients Failing Antiretroviral Therapy

Mutations in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and protease that confer resistance to antiretroviral agents are usually accompanied by a reduction in the viral replicative capacity under drug-free conditions. Consequently, when antiretroviral treatment is interrupted...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hance, Allan J., Lemiale, Virginie, Izopet, Jacques, Lecossier, Denise, Joly, Véronique, Massip, Patrice, Mammano, Fabrizio, Descamps, Diane, Brun-Vézinet, Françoise, Clavel, François
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2001
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC114364/
https://ncbi.nlm.nih.gov/pubmed/11413308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.75.14.6410-6417.2001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak